The global launch of the LYMA Laser Pro in 2025 marks a watershed moment in beauty technology, a clinic-grade, near-infrared laser system bringing professional-level anti-aging results into homes and spas worldwide. Building on the original LYMA Laser’s international acclaim, the Pro takes non-invasive facial and body rejuvenation to new scientific heights, promising collagen renewal without compromise.
Cold Laser Power—No Pain, No Downtime
Unlike traditional cosmetic lasers that trigger inflammation by damaging the skin, the LYMA Laser Pro uses cold laser technology—a 1450mW near-infrared laser at 808nm—to reach deep into the dermis without damaging the surface or triggering inflammation. No heat. No trauma. No recovery time.
Instead of inflicting damage to create collagen, which results in inflammation and diminished collagen production, as the body prioritizes speed of healing over the quality of collagen produced; the LYMA Laser and LYMA Laser PRO signals the next generation of skin transformation. The only cosmetic…
laser technology engineered to switch skin into youth mode completely naturally and painlessly.
Clinic-Grade Results at Home and for All Skin Tones Engineered by leading laser scientists, plastic surgeons, and geneticists, the Pro features a patented 30cm² lens (three times larger than the original) and delivers monochromatic, coherent, and polarized near-infrared low-level laser technology to transform skin, with zero pain, zero damage, and zero downtime.
Clinical findings speak for themselves: 103% increase in skin elasticity in 30 days. A record for clinically tested skin transformation. 46% reduction in pigmentation over 6 weeks of regular use.
Five academic papers published in the Aesthetic Surgery Journal, including two world-firsts on the clinical applications of low-level laser photobiomodulation and the first study into gene expression in the dermis, proving that LYMA Laser technology expressed genes while LED only expressed one…
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.